Douglas Hughes

Douglas Hughes

Directeur/Membre du Conseil chez IMMUNOVANT, INC.

Fortune : 5 M $ au 30/06/2026

64 ans
Health Technology
Consumer Services
Consumer Non-Durables

Profil

Douglas Hughes is currently Director at Immunovant Sciences Ltd. since 2019, Independent Director at Immunovant, Inc. since 2019, Chief Financial Officer & Director at Calyxo, Inc. since 2018, and Chief Financial Officer at Calyxo USA, Inc. since 2019.
Former roles include Director-Investor Relations at The Clorox Co., Independent Non-Executive Director at Eargo, Inc. from 2020 to 2022, Director at Immunovant, Inc., Vice President-Investor Relations at Guidant Corp., Vice President-Finance & Administration at Boston Scientific Corp., Chief Operating & Financial Officer at Nellix, Inc. from 2010 to 2011, Chief Financial Officer at NeoTract, Inc. from 2011 to 2018, Chief Financial Officer at Evalve, Inc. from 2009 to 2010, and Chief Financial Officer at Maquet.
Education includes an MBA from The University of Chicago and undergraduate studies at San Francisco State University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/04/2026 134 653 ( 0,07 % ) 5 M $ 30/06/2026

Postes actifs de Douglas Hughes

SociétésPosteDébut
IMMUNOVANT, INC. Directeur/Membre du Conseil 18/12/2019
Directeur Financier/CFO 01/01/2019
Directeur/Membre du Conseil 01/10/2019
Directeur Financier/CFO 01/01/2018

Anciens postes connus de Douglas Hughes

SociétésPosteFin
EARGO, INC. Directeur/Membre du Conseil 07/12/2022
Directeur Financier/CFO 01/01/2018
Public Communications Contact 01/04/2011
Directeur Financier/CFO 01/01/2011
Directeur Financier/CFO 01/01/2010
Voir l'expérience en détail de Douglas Hughes

Formation de Douglas Hughes

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

16

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Distribution Services

Industrial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Douglas Hughes
🔇